6.3.1.5 SGLT2 - (gliflozin)
Drug safety update: SGLT2 inhibitors (Canagliflozin, Dapagliflozin, Empagliflozin) risk of diabetic ketoacidosis.
For more information Click Here (pdf)
Dapagliflozin - Type 2 Diabetes
For NICE Guideline NG28 Type 2 diabetes in adults: management Click Here
SGLT2 - Chronic Kidney Disease (CKD) in Adults
For Primary Care Guidance - SGLT2 inhibitors for Chronic Kidney Disease (CKD) in Adults and NICE TA775 Dapagliflozin for treating chronic kidney disease Click Here
Finerenone - Option for treating stage 3 and 4 chronic kidney disease (with albuminuria) associated with type 2 diabetes in adults (only for this indication).
For NICE TA 877 Finerenone for treating chronic kidney disease in type 2 diabetesClick Here
For Finerenone - 2.5.1. Potassium-Sparing Diuretics (Aldosterone antagonists)Click Here
For SGLTi Top Tips Click Here
Primary care initiation must be supplemented with the addition of the indication (Heart failure with reduced ejection fraction/Type 2 diabetes mellitus/Chronic Kidney Disease) for initiation in the consultation notes / medication screen & linked to associated problem.
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
- First Line Choice
- On Formulary
- Specialist Initiation Only
- Hospital Only
- KMPT Initiation Only